HealthLeaders Media July 27, 2020
Jack O'Brien

President Trump is scheduled to meet with pharmaceutical executives about the “most favored nation model” order on Tuesday.

Avalere Health released an analysis Sunday of four executive orders on prescription drug prices released by President Donald Trump late last week.

The Washington, D.C.-based consulting firm broke down the three orders signed by Trump in a ceremony Friday, as well as one order that was announced but isn’t expected to be signed until late August.

As part of the executive orders, federal qualified community health centers (FQHC) will now be required to make insulin and Epipen available to patients at the 340B Discount Drug Pricing Program price and states will be allowed to import prescription drugs from Canada and other countries.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Regulations
What Fishing Can Teach Us About Lowering Healthcare Costs
Drug Expenditures Surge. Drug Prices Don't.
Weight-Loss Drugs Drive U.S. Prescription Spending
Why Are Cash Prices Lower Than Health Insurance Negotiated Prices?
STAT+: Hospital price transparency rules are seeding a new crop of health tech startups

Share This Article